Skip to main content
Top
Published in: European Journal of Nutrition 6/2015

01-09-2015 | Original Contribution

Benefits of foods supplemented with vegetable oils rich in α-linolenic, stearidonic or docosahexaenoic acid in hypertriglyceridemic subjects: a double-blind, randomized, controlled trail

Authors: Manja Dittrich, Gerhard Jahreis, Kristin Bothor, Carina Drechsel, Michael Kiehntopf, Matthias Blüher, Christine Dawczynski

Published in: European Journal of Nutrition | Issue 6/2015

Login to get access

Abstract

Purpose

The aim of the study was to investigate the influence of foods enriched with vegetable oils varying in their n-3 polyunsaturated fatty acids profile on cardiovascular risk factors for hypertriglyceridemic subjects.

Methods

Fifty-nine hypertriglyceridemic subjects (triglycerides ≥ 1.5 mmol/L) were included in the randomized, double-blind, placebo-controlled, crossover study. The placebo group received sunflower oil [linoleic acid (LA) group; 10 g LA/day]. The intervention groups received linseed oil [α-linolenic acid (ALA) group; 7 g ALA/day], echium oil [stearidonic acid (SDA) group; 2 g SDA/day] or microalgae oil [docosahexaenoic acid (DHA) group; 2 g DHA/day] over 10 weeks. Blood samples were collected at baseline and at the end of each period.

Results

Total cholesterol (TC) and low-density-lipoprotein cholesterol decreased significantly in the LA and ALA groups (LA: P ≤ 0.01, ALA: P ≤ 0.05). No changes in blood lipids were observed in the SDA group. Significant increases in TC and high-density-lipoprotein cholesterol occurred in the DHA group (P ≤ 0.05). In the ALA and SDA groups, the content of eicosapentaenoic acid in erythrocyte lipids increased significantly (P ≤ 0.05) after 10 weeks (ALA group: 38 ± 37 %, SDA group: 73  ± 59 %).

Conclusion

Foods enriched with different vegetable oils rich in ALA or SDA are able to increase the n-3 long-chain polyunsaturated fatty acids content in erythrocyte lipids; echium oil is more potent in comparison with linseed oil. Blood lipids were beneficially modified through the consumption of food products enriched with sunflower, linseed and microalgae oils, whereas echium oil did not affect blood lipids. ClinicalTrials.gov: NCT01437930.
Literature
1.
go back to reference Wang C, Harris WS et al (2006) n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84(1):5–17 Wang C, Harris WS et al (2006) n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84(1):5–17
2.
go back to reference Wei MY, Jacobson TA (2011) Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Curr Atheroscler Rep 13(6):474–483CrossRef Wei MY, Jacobson TA (2011) Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Curr Atheroscler Rep 13(6):474–483CrossRef
3.
go back to reference Simopoulos AP (2008) The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 233:674–688CrossRef Simopoulos AP (2008) The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 233:674–688CrossRef
4.
go back to reference Deutsche Gesellschaft für Ernährung e.V. (DGE; 2012). 12. Ernährungsbericht 2012 (Nutrition Report 2012) Bonn, ISBN 978-3-88749-232-8 Deutsche Gesellschaft für Ernährung e.V. (DGE; 2012). 12. Ernährungsbericht 2012 (Nutrition Report 2012) Bonn, ISBN 978-3-88749-232-8
5.
go back to reference EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2012) Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA J 10(7):2815. doi:10.2903/j.efsa.2012.2815 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2012) Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA J 10(7):2815. doi:10.​2903/​j.​efsa.​2012.​2815
6.
go back to reference Hooper L, Summerbell CD et al (2011) Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 7:CD002137 Hooper L, Summerbell CD et al (2011) Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 7:CD002137
7.
go back to reference Folch J, Lees M et al (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226(1):497–509 Folch J, Lees M et al (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226(1):497–509
8.
go back to reference Dawczynski C, Massey KA et al (2012) Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors. Clin Nutr 32(5):686–696CrossRef Dawczynski C, Massey KA et al (2012) Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors. Clin Nutr 32(5):686–696CrossRef
9.
go back to reference Kuhnt K, Wagner A, Kraft J et al (2006) Dietary supplementation with 11 trans- and 12 trans-18:1 and oxidative stress in humans. Am J Clin Nutr 84:981–988 Kuhnt K, Wagner A, Kraft J et al (2006) Dietary supplementation with 11 trans- and 12 trans-18:1 and oxidative stress in humans. Am J Clin Nutr 84:981–988
10.
go back to reference Strobel C, Jahreis G et al (2012) Survey of n-3 and n-6 polyunsaturated fatty acids in fish and fish products. Lipids Health Dis 11:144CrossRef Strobel C, Jahreis G et al (2012) Survey of n-3 and n-6 polyunsaturated fatty acids in fish and fish products. Lipids Health Dis 11:144CrossRef
11.
go back to reference Bluher M, Rudich A et al (2012) Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 35(2):342–349CrossRef Bluher M, Rudich A et al (2012) Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 35(2):342–349CrossRef
12.
go back to reference Katan MB, Deslypere JP et al (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38(10):2012–2022 Katan MB, Deslypere JP et al (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38(10):2012–2022
13.
go back to reference Sprecher H, Chen Q et al (1999) Regulation of the biosynthesis of 22:5n-6 and 22:6n-3: a complex intracellular process. Lipids 34:S153–S156CrossRef Sprecher H, Chen Q et al (1999) Regulation of the biosynthesis of 22:5n-6 and 22:6n-3: a complex intracellular process. Lipids 34:S153–S156CrossRef
14.
go back to reference Deckelbaum RJ (2010) n-6 and n-3 Fatty acids and atherosclerosis: ratios or amounts? Arterioscler Thromb Vasc Biol 30(12):2325–2326CrossRef Deckelbaum RJ (2010) n-6 and n-3 Fatty acids and atherosclerosis: ratios or amounts? Arterioscler Thromb Vasc Biol 30(12):2325–2326CrossRef
15.
go back to reference Goyens PL, Spilker ME et al (2006) Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 84(1):44–53 Goyens PL, Spilker ME et al (2006) Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 84(1):44–53
16.
go back to reference James MJ, Ursin VM et al (2003) Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr 77(5):1140–1145 James MJ, Ursin VM et al (2003) Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr 77(5):1140–1145
17.
go back to reference Voss A et al (1991) The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 266(30):19995–20000 Voss A et al (1991) The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 266(30):19995–20000
18.
go back to reference Brossard N et al (1996) Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr 64(4):577–586 Brossard N et al (1996) Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr 64(4):577–586
19.
go back to reference Kelley DS, Siegel D et al (2007) Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 86(2):324–333 Kelley DS, Siegel D et al (2007) Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 86(2):324–333
20.
go back to reference Adam O, Wolfram G et al (2003) Influence of dietary linoleic acid intake with different fat intakes on arachidonic acid concentrations in plasma and platelet lipids and eicosanoid biosynthesis in female volunteers. Ann Nutr Metab 47(1):31–36CrossRef Adam O, Wolfram G et al (2003) Influence of dietary linoleic acid intake with different fat intakes on arachidonic acid concentrations in plasma and platelet lipids and eicosanoid biosynthesis in female volunteers. Ann Nutr Metab 47(1):31–36CrossRef
21.
go back to reference Young GS et al (2005) Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Reprod Nutr Dev 45(5):549–558CrossRef Young GS et al (2005) Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Reprod Nutr Dev 45(5):549–558CrossRef
22.
go back to reference Ramsden CE et al (2010) n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 104(11):1586–1600CrossRef Ramsden CE et al (2010) n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 104(11):1586–1600CrossRef
23.
go back to reference Harris WS, Von Schacky C (2004) The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 39(1):212–220CrossRef Harris WS, Von Schacky C (2004) The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 39(1):212–220CrossRef
24.
go back to reference Harris WS (2007) Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 55(3):217–223CrossRef Harris WS (2007) Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 55(3):217–223CrossRef
25.
go back to reference Lemke SL, Vicini JL et al (2010) Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr 92(4):766–775CrossRef Lemke SL, Vicini JL et al (2010) Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr 92(4):766–775CrossRef
26.
go back to reference Jenkinson AM, Collins AR et al (1999) The effect of increased intakes of polyunsaturated fatty acids and vitamin E on DNA damage in human lymphocytes. FASEB J 13(15):2138–2142 Jenkinson AM, Collins AR et al (1999) The effect of increased intakes of polyunsaturated fatty acids and vitamin E on DNA damage in human lymphocytes. FASEB J 13(15):2138–2142
27.
go back to reference Koenig W et al (2011) Oxidized LDL and the risk of coronary heart disease: results from the MONICA/KORA Augsburg study. Clin Chem 57(8):1196–1200CrossRef Koenig W et al (2011) Oxidized LDL and the risk of coronary heart disease: results from the MONICA/KORA Augsburg study. Clin Chem 57(8):1196–1200CrossRef
28.
go back to reference Binkoski AE, Kris-Etherton PM et al (2005) Balance of unsaturated fatty acids is important to a cholesterol-lowering diet: comparison of mid-oleic sunflower oil and olive oil on cardiovascular disease risk factors. J Am Diet Assoc 105(7):1080–1086CrossRef Binkoski AE, Kris-Etherton PM et al (2005) Balance of unsaturated fatty acids is important to a cholesterol-lowering diet: comparison of mid-oleic sunflower oil and olive oil on cardiovascular disease risk factors. J Am Diet Assoc 105(7):1080–1086CrossRef
29.
go back to reference Czernichow S et al (2010) n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr 104(6):788–796CrossRef Czernichow S et al (2010) n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr 104(6):788–796CrossRef
30.
go back to reference Gillingham LG, Gustafson JA et al (2011) High-oleic rapeseed (canola) and flaxseed oils modulate serum lipids and inflammatory biomarkers in hypercholesterolaemic subjects. Br J Nutr 105(3):417–427CrossRef Gillingham LG, Gustafson JA et al (2011) High-oleic rapeseed (canola) and flaxseed oils modulate serum lipids and inflammatory biomarkers in hypercholesterolaemic subjects. Br J Nutr 105(3):417–427CrossRef
31.
go back to reference Whelan J, Gouffon J et al (2012) Effects of dietary stearidonic acid on biomarkers of lipid metabolism. J Nutr 142(3):630S–634SCrossRef Whelan J, Gouffon J et al (2012) Effects of dietary stearidonic acid on biomarkers of lipid metabolism. J Nutr 142(3):630S–634SCrossRef
32.
go back to reference Surette ME, Edens M et al (2004) Dietary echium oil increases plasma and neutrophil long-chain (n-3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans. J Nutr 134(6):1406–1411 Surette ME, Edens M et al (2004) Dietary echium oil increases plasma and neutrophil long-chain (n-3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans. J Nutr 134(6):1406–1411
33.
go back to reference Egert S et al (2009) Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J Nutr 139(5):861–868CrossRef Egert S et al (2009) Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J Nutr 139(5):861–868CrossRef
34.
go back to reference Kamstrup PR, Tybjaerg-Hansen A et al (2013) Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. J Am Coll Cardiol 61(11):1146–1156CrossRef Kamstrup PR, Tybjaerg-Hansen A et al (2013) Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. J Am Coll Cardiol 61(11):1146–1156CrossRef
35.
go back to reference Triffitt JT, Gebauer U et al (1976) Origin of plasma alpha2HS-glycoprotein and its accumulation in bone. Nature 262(5565):226–227CrossRef Triffitt JT, Gebauer U et al (1976) Origin of plasma alpha2HS-glycoprotein and its accumulation in bone. Nature 262(5565):226–227CrossRef
36.
go back to reference Jung CH, Kim BY et al (2013) Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes. Diab Vasc Dis Res 10(5):459–467CrossRef Jung CH, Kim BY et al (2013) Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes. Diab Vasc Dis Res 10(5):459–467CrossRef
37.
go back to reference Ix JH, Shlipak MG et al (2006) Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 113(14):1760–1767CrossRef Ix JH, Shlipak MG et al (2006) Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 113(14):1760–1767CrossRef
38.
go back to reference Himmetoglu S, Teksoz S et al (2013) Serum levels of fetuin A and 8-hydroxydeoxyguanosine in morbidly obese subjects. Exp Clin Endocrinol Diabetes 121(8):505–508CrossRef Himmetoglu S, Teksoz S et al (2013) Serum levels of fetuin A and 8-hydroxydeoxyguanosine in morbidly obese subjects. Exp Clin Endocrinol Diabetes 121(8):505–508CrossRef
39.
go back to reference Roos M, von Eynatten M et al (2010) Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease. Am J Cardiol 105(12):1666–1672CrossRef Roos M, von Eynatten M et al (2010) Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease. Am J Cardiol 105(12):1666–1672CrossRef
40.
go back to reference Reynolds JL, Skepper JN et al (2005) Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16(10):2920–2930CrossRef Reynolds JL, Skepper JN et al (2005) Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16(10):2920–2930CrossRef
41.
go back to reference Stenvinkel P, Wang K et al (2005) Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 67(6):2383–2392CrossRef Stenvinkel P, Wang K et al (2005) Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 67(6):2383–2392CrossRef
42.
go back to reference Mori K et al (2007) Association of serum fetuin-A with carotid arterial stiffness. Clin Endocrinol (Oxf) 66(2):246–250CrossRef Mori K et al (2007) Association of serum fetuin-A with carotid arterial stiffness. Clin Endocrinol (Oxf) 66(2):246–250CrossRef
43.
go back to reference An WS, Lee SM et al (2012) Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients. Nutr Res 32(7):495–502CrossRef An WS, Lee SM et al (2012) Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients. Nutr Res 32(7):495–502CrossRef
44.
go back to reference Ozyazgan S, Karaoglu K et al (2013) Effects of omega-3 polyunsaturated fatty acid supplementation on serum fetuin-A levels in type 2 diabetic patients. Minerva Med 104(3):287–293 Ozyazgan S, Karaoglu K et al (2013) Effects of omega-3 polyunsaturated fatty acid supplementation on serum fetuin-A levels in type 2 diabetic patients. Minerva Med 104(3):287–293
Metadata
Title
Benefits of foods supplemented with vegetable oils rich in α-linolenic, stearidonic or docosahexaenoic acid in hypertriglyceridemic subjects: a double-blind, randomized, controlled trail
Authors
Manja Dittrich
Gerhard Jahreis
Kristin Bothor
Carina Drechsel
Michael Kiehntopf
Matthias Blüher
Christine Dawczynski
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 6/2015
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-014-0764-2

Other articles of this Issue 6/2015

European Journal of Nutrition 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.